CPI Logo-Color.png
Constellation Pharmaceuticals Announces Second-Quarter and Six-Month 2018 Financial Results
August 14, 2018 16:15 ET | Constellation Pharmaceuticals , Inc.
Company raises an aggregate of $160 million in crossover financing in April and initial public offering (IPO) in JulyCompany progressing its pipeline, including clinical programs CPI-1205 and CPI-0610...
Constellation Pharma
Constellation Pharmaceuticals Announces Pricing of Initial Public Offering
July 18, 2018 19:56 ET | Constellation Pharmaceuticals , Inc.
CAMBRIDGE, Mass., July 18, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (the “Company”)(Nasdaq:CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to...